Skip to content Skip to footer
Subscribe Now
Viewpoints_Jesse Mendelsohn
VIEWPOINTS

Predicting 2025 Trends: Jesse Mendelsohn from Model N in an Illuminating Discussion with PharmaShots

Shots: Several undulating factors coalesce to inadvertently shape the biopharma industry Prominent challenges include mounting pressure on Pharmacy Benefit Managers from independent pharmacies and drug manufacturers, a growing shortage of GLP-1 drugs, and the addition of 15 more drugs to the Inflation Reduction Act’s price negotiation list. Jesse Mendelsohn, SVP at Model N, emphasizes the…
April 28, 2025

Read more

VIEWPOINTS_Kyle Forcier_2023
VIEWPOINTS

In a gripping conversation with PharmaShots, Kyle Forcier addresses the ways to avoid the challenges of the 340B program

Shots: Kyle Forcier, Sr. Director of Life Science Product Marketing at Model N, addresses the challenges of the 340B program and ways manufacturers can mitigate them and emerge stronger  340B, a US federal government plan, enables eligible healthcare organizations and covered entities to receive outpatient drugs from drug manufacturers at significantly low prices  Kyle recalls…
October 23, 2023

Read more